MVP 1.15% 44.0¢ medical developments international limited

Back in October 2017 the guidance was "At this stage, we expect...

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 72 Posts.
    Back in October 2017 the guidance was "At this stage, we expect the H1FY18 results to be in line with H1FY17". so the results is in line with the guidance.

    Sales of penthrox in the H1 2017 were very high as stock was sent to fill initial orders to new markets. This was a known 1 off and the reason why expectations for for no growth for H1 2018 compared to H1 2017.

    the company was very open about this and it was not a surprise.

    That does not mean there will not be a sell off in share price today as there is high expectations for future growth already in the price.
    Last edited by g3xu8: 16/02/18
 
watchlist Created with Sketch. Add MVP (ASX) to my watchlist
(20min delay)
Last
44.0¢
Change
0.005(1.15%)
Mkt cap ! $49.56M
Open High Low Value Volume
44.0¢ 44.5¢ 43.8¢ $35.20K 79.81K

Buyers (Bids)

No. Vol. Price($)
1 9584 44.0¢
 

Sellers (Offers)

Price($) Vol. No.
45.0¢ 1000 1
View Market Depth
Last trade - 16.10pm 14/11/2024 (20 minute delay) ?
MVP (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.